Theriva Biologics TOVX Q1 2026 Earnings Slight EPS Beat Boosts Sentiment for ClinicalStage Biotech bioAffinity Technologies BIAF Q3 2025 Earnings Significant EPS Miss as Revenue Remains Zero Stock Declines 37 LIND Q1 2026 Earnings Stellar EPS Surprise of 452 Drives Stock Rally NATH Q4 2024 Earnings EPS of 096 Reported Amid Modest Stock Reaction CHA Q4 2025 Earnings EPS Misses Estimates by Wide Margin Mirion Technologies Q1 2026 Earnings EPS Beats Estimates Stock Rises Over 4 Porch Group Inc PRCH Q1 2026 Earnings EPS Surprises Positively Stock Edges Lower PLDT Inc PHI Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady PM Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Pricing and Volume Mix APLE Q1 2026 Earnings EPS Misses Estimates Yet Stock Rises HEI Q4 2025 Earnings EPS Surprise Beats Estimates Despite Tepid Market Response SHIP Q4 2025 Earnings EPS Surpasses Estimates by 163 as Stock Slips on Broader Market Sentiment DAWN Q4 2025 Earnings Miss on EPS as PreRevenue Biotech Invests in Pipeline